Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS. Wefel JS, et al. Among authors: wen py. Neuro Oncol. 2011 Jun;13(6):660-8. doi: 10.1093/neuonc/nor024. Epub 2011 May 9. Neuro Oncol. 2011. PMID: 21558074 Free PMC article. Clinical Trial.
Uncommon brain tumors.
Schiff D, Wen PY. Schiff D, et al. Among authors: wen py. Neurol Clin. 1995 Nov;13(4):953-74. Neurol Clin. 1995. PMID: 8584006 Review.
Neurologic emergencies in cancer patients.
Schiff D, Batchelor T, Wen PY. Schiff D, et al. Among authors: wen py. Neurol Clin. 1998 May;16(2):449-83. doi: 10.1016/s0733-8619(05)70072-4. Neurol Clin. 1998. PMID: 9537970 Review.
Therapy for recurrent malignant glioma in adults.
Mrugala MM, Kesari S, Ramakrishna N, Wen PY. Mrugala MM, et al. Among authors: wen py. Expert Rev Anticancer Ther. 2004 Oct;4(5):759-82. doi: 10.1586/14737140.4.5.759. Expert Rev Anticancer Ther. 2004. PMID: 15485312 Review.
Medical management of patients with brain tumors.
Wen PY, Schiff D, Kesari S, Drappatz J, Gigas DC, Doherty L. Wen PY, et al. J Neurooncol. 2006 Dec;80(3):313-32. doi: 10.1007/s11060-006-9193-2. Epub 2006 Jun 29. J Neurooncol. 2006. PMID: 16807780 Review.
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD. Cloughesy TF, et al. Among authors: wen py. J Clin Oncol. 2006 Aug 1;24(22):3651-6. doi: 10.1200/JCO.2006.06.2323. J Clin Oncol. 2006. PMID: 16877733 Clinical Trial.
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. Wen PY, et al. Clin Cancer Res. 2006 Aug 15;12(16):4899-907. doi: 10.1158/1078-0432.CCR-06-0773. Clin Cancer Res. 2006. PMID: 16914578 Clinical Trial.
632 results